Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-5_03-cv-05669/USCOURTS-cand-5_03-cv-05669-63/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

FENWICK 

&

WEST LLP ATTORNEYS AT LAW

MOUNTAIN VIEW

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

JOINT CASE MANAGEMENT STATEMENT CASE NO. C 03 05669 JW (RS)

[List of Counsel Appears on Last Page] 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

THE REGENTS OF THE UNIVERSITY OF 

CALIFORNIA, 

Plaintiff, 

v. 

MICRO THERAPEUTICS, INC., a Delaware 

corporation, DENDRON GmbH, a German 

corporation, and ev3 INC., a Delaware 

corporation, 

Defendant, 

Case No. C 03 05669 JW (RS) 

JOINT CASE MANAGEMENT STATEMENT 

PURSUANT TO THE COURT’S 

DECEMBER 3, 2007 MINUTE ORDER

Date: January 14, 2007 

Time: 10:00 a.m. 

Courtroom: Hon. James Ware 

 Courtroom 8 

MICRO THERAPEUTICS, INC., a Delaware 

corporation, and DENDRON GmbH, a German 

corporation, 

Third Party Plaintiffs, 

v. 

BOSTON SCIENTIFIC CORPORATION, 

a Delaware corporation, and TARGET 

THERAPEUTICS, INC. a Delaware corporation, 

Third Party Defendants. 

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORN

I

A

IT IS SO ORDERED

Judge James Ware

ORDER CONTINUING STATUS 

CONFERENCE RE: SETTLEMENT

Case 5:03-cv-05669-JW Document 978 Filed 01/10/08 Page 1 of 2
FENWICK 

&

WEST LLP ATTORNEYS AT LAW

MOUNTAIN VIEW

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

JOINT CASE MANAGEMENT STATEMENT - 2 - CASE NO. C 03 05669 JW (RS)

The parties jointly submit this Case Management Statement pursuant to the Court’s 

December 3, 2007 Minute Order (Dkt. No. 971). Plaintiff and Counterdefendant The Regents of 

the University of California and Defendants and Counterclaimants Micro Therapeutics, Inc., 

Dendron GmbH and ev3 Inc. (“MTI”), have reached a settlement agreement in principle that 

would resolve the pending patent litigation. They are in the process of finalizing the written 

settlement agreement, which incorporates separate agreements between MTI and Third Party 

Defendants Boston Scientific Corporation and Target Therapeutics, Inc. The parties anticipate 

that they will have a draft that is ready to be signed within the next ten to fifteen days. They 

expect they will have a stipulated dismissal filed on or before January 30, 2008. 

Dated: January 4, 2008 By: /s/ Patrick Premo 

Lynn H. Pasahow (SBN 054283) 

Patrick E. Premo (SBN 184915) 

FENWICK & WEST LLP 

Silicon Valley Center 

801 California Street 

Mountain View, California 94041 

Telephone: (650) 335-7460 

Attorneys for Plaintiff/Counterdefendant 

THE REGENTS OF THE UNIVERSITY OF 

CALIFORNIA

Dated: January 4, 2008 By: /s/ Michelle Umberger 

John S. Skilton (Pro Hac Vice) 

Michelle M. Umberger (Pro Hac Vice) 

HELLER EHRMAN LLP 

One East Main Street, Suite 201 

Madison, Wisconsin 53703 

Telephone (608) 663-7460 

Attorneys for Defendants/Counterclaimants 

MICRO THERAPEUTICS, INC., DENDRON GMBH

AND Ev3 INC. 

1278254 

*** ORDER ***

 Pursuant to the representations above, the Court continues the Status Conference Re: 

Settlement to give the parties sufficient time to complete their settlement papers and file the 

appropriate stipulated dismissal. The Court continues the Status Conference from January 14, 2008 

to February 11, 2008 at 10 A.M. If the Stipulated Dismissal is filed on or before February 4, 

2008, the Status Conference will be vacated. If a dismissal is not on file, the parties shall file a 

Joint Statement informing the Court of the status of the case on or before February 4, 2008.

Dated: January 10, 2008 ____________________________________ 

 JAMES WARE 

 United States District Judge

Case 5:03-cv-05669-JW Document 978 Filed 01/10/08 Page 2 of 2